The WEB™ Aneurysm Embolization System expands with a lower profile delivery system and new size configurations. ALISO VIEJO, Calif., Jan. 12, 2021 /PRNewswire/ -- MicroVention, Inc., a U.S.-based ...

SAN DIEGO & ALISO VIEJO, Calif.--(BUSINESS WIRE)--MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, announced the publication of WEB-IT 5-year ...

ALISO VIEJO, Calif., March 19, 2025 /PRNewswire/ -- Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, proudly marks the 15th anniversary of ...

For the new study, Dr. Adeeb and colleagues compared the WEB device in bifurcation and sidewall aneurysms using a large database spanning more than 10 years from the WorldWideWEB consortium, a group ...

ALISO VIEJO, Calif., Sequent Medical, Inc. a privately held venture backed medical device company dedicated to the development of innovative catheter-based neurovascular technologies, announced today ...

Sequent Medical, Inc. announced today the presentation of long-term results from a retrospective study of the WEB™ Aneurysm Embolization System at the World Federation of Interventional Neuroradiology ...

Terumo Corporation’s (TRUMY) wholly-owned subsidiary MicroVention, Inc. recently announced the publication of the Clinical Evaluation of WEB 17 Device in Intracranial Aneurysms (CLEVER) study results.

ALISO VIEJO, California, May 20, 2013 /PRNewswire/ -- Sequent Medical, Inc. announced today that it has received CE mark for the SL ("Single Layer") family of WEB® Aneurysm Embolization Devices, and ...

ALISO VIEJO, California, Feb. 12, 2016 /PRNewswire/ -- Sequent Medical, Inc. announced today that it has commenced patient enrollment in a study to evaluate the safety and effectiveness of the WEB™ ...

ALISO VIEJO, Calif. , Jan. 12, 2021 /PRNewswire/ -- MicroVention, Inc., a U.S.-based subsidiary of Terumo and a global neurovascular company, announced today the FDA Approval of the PMA Supplement for ...